Triple reversal phenomenon in EGFR-mutant lung adenocarcinoma with prostate metastasis following hepatocellular carcinoma: a rare Case Report with diagnostic and therapeutic implications
BackgroundNon-small cell lung cancer harboring EGFR mutations is responsive to targeted therapies such as Osimertinib. Although metastasis from lung cancer to the prostate is exceedingly rare, we present a rare case of prostatic metastasis from lung adenocarcinoma in a patient with a history of hepa...
Saved in:
Main Authors: | Jieyan Luo, Jie Zhou, Li Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1619466/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma
by: E. V. Levchenko, et al.
Published: (2023-02-01) -
Superposition of lung metastases of prostate adenocarcinoma on heart as a cardiac metastases: A case report
by: Turgut Kacan, et al.
Published: (2016-08-01) -
Integrated Traditional Chinese and Western Medicine in Lung Adenocarcinoma with Rare EGFR Mutation and Nephrotic Syndrome: A Case Report
by: Zhang L, et al.
Published: (2025-07-01) -
Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation
Sensitive to Furmonertinib: A Case Report
by: Rongzhen LI, et al.
Published: (2025-06-01) -
Tumor-to-Tumor Metastasis of Prostatic Adenocarcinoma in Transitional Meningioma: A Case Report and Literature Review
by: Rafael Harter Tomaszeski, et al.
Published: (2025-06-01)